|
O.D. Ostroumova, A.V. Dubinina, V.A. De, A.I. Kochetkov, V.B. Dashabylova, S.S. Eremina, M.V. Klepikova
On the issue of improving the safety of antithrombotic therapy in patients with atrial fibrillation and coronary heart disease receiving antithrombotic therapy
|
№14 / 2023
|
|
O.D. Ostroumova, I.Yu. Orlova, A.I. Kochetkov, O.A. Polyakova, A.I. Listratov, N.A. Shatalova, S.V. Batyukina
Structure of prescription of gastroprotective drugs in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study
|
№13 / 2022
|
|
D.I. Trukhan, D.S. Ivanova
Drug safety in real clinical practice: focus on protective therapy
|
№3 / 2022
|
|
V.I. Simanenkov, N.V. Bakulina, Т.S. Fil, A.Kh. Khubieva
EVALUATION OF EFFICIENCY OF H. PYLORI ERADICATION IN CASE OF ADDITION OF CYTOPROTECTIVE PREPARATION REBAMIPIDE TO THE TREATMENT: RESULTS OF THE BASTION TRIAL
|
№s5-17 / 2017
|
|
T.A. Sivokhina, M.V. Kozhina
EXPERIENCE OF THE USE OF CYTOPROTECTOR REBAMIPIDE IN THE TREATMENT OF NSAID-INDUCED EROSIVE GASTROPATHY
|
№18 / 2017
|
Русский
